Poliwoda H - Search Results

1

Biologic and therapeutic efficacy of mafosfamide in patients with metastatic renal cell carcinoma.

Schomburg A, Menzel T, Hadam M, Duensing S, Körfer A, Kirchner H, Poliwoda H, Atzpodien J. Schomburg A, et al. Among authors: poliwoda h. Mol Biother. 1992 Jun;4(2):58-65. Mol Biother. 1992. PMID: 1515095

2

Diminished expression of interleukin-2 receptors in vivo after prior chemotherapy in advanced cancer patients receiving recombinant interleukin-2.

Atzpodien J, Körfer A, Hadam M, Schomburg A, Menzel T, Dallmann I, Poliwoda H, Kirchner H. Atzpodien J, et al. Among authors: poliwoda h. Mol Biother. 1991 Jun;3(2):60-2. Mol Biother. 1991. PMID: 1910621

3

alpha-Interferon and interleukin-2 in renal cell carcinoma: studies in nonhospitalized patients.

Atzpodien J, Poliwoda H, Kirchner H. Atzpodien J, et al. Among authors: poliwoda h. Semin Oncol. 1991 Oct;18(5 Suppl 7):108-12. Semin Oncol. 1991. PMID: 1948123 Clinical Trial.

4

Subcutaneous interleukin-2 and interferon-alpha 2b in patients with metastatic renal cell cancer: the German outpatient experience.

Kirchner H, Körfer A, Palmer PA, Evers P, De Riese W, Knüver-Hopf J, Hadam M, Goldman U, Franks CR, Poliwoda H, et al. Kirchner H, et al. Among authors: poliwoda h. Mol Biother. 1990 Sep;2(3):145-54. Mol Biother. 1990. PMID: 2222898

5

Treatment of metastatic renal cell cancer patients with recombinant subcutaneous human interleukin-2 and interferon-alpha.

Atzpodien J, Körfer A, Palmer PA, Franks CR, Poliwoda H, Kirchner H. Atzpodien J, et al. Among authors: poliwoda h. Ann Oncol. 1990 Sep;1(5):377-8. doi: 10.1093/oxfordjournals.annonc.a057779. Ann Oncol. 1990. PMID: 2261378 Free article. Clinical Trial.

6

Biochemotherapy of advanced metastatic renal-cell carcinoma: results of the combination of interleukin-2, alpha-interferon, 5-fluorouracil, vinblastine, and 13-cis-retinoic acid.

Atzpodien J, Kirchner H, Duensing S, Lopez Hänninen E, Franzke A, Buer J, Probst M, Anton P, Poliwoda H. Atzpodien J, et al. Among authors: poliwoda h. World J Urol. 1995;13(3):174-7. doi: 10.1007/BF00184875. World J Urol. 1995. PMID: 7550391 Clinical Trial.

7

Lack of therapeutic efficacy of tamoxifen in advanced renal cell carcinoma.

Schomburg A, Kirchner H, Fenner M, Menzel T, Poliwoda H, Atzpodien J. Schomburg A, et al. Among authors: poliwoda h. Eur J Cancer. 1993;29A(5):737-40. doi: 10.1016/s0959-8049(05)80357-0. Eur J Cancer. 1993. PMID: 7682428 Clinical Trial.

8

Low-dose interleukin-2 in combination with interferon-alpha effectively modulates biological response in vivo.

Schneekloth C, Körfer A, Hadam M, Lopez Hänninen E, Menzel T, Schomburg A, Dallmann I, Kirchner H, Poliwoda H, Atzpodien J. Schneekloth C, et al. Among authors: poliwoda h. Acta Haematol. 1993;89(1):13-21. doi: 10.1159/000204476. Acta Haematol. 1993. PMID: 7683166

9

Interferon-alpha/5-fluorouracil: a novel outpatient chemo/immunotherapy for progressive metastatic renal cell carcinoma.

Lopez Hanninen E, Poliwoda H, Atzpodien J. Lopez Hanninen E, et al. Among authors: poliwoda h. Cancer Biother. 1995 Spring;10(1):21-4. doi: 10.1089/cbr.1995.10.21. Cancer Biother. 1995. PMID: 7780483

10

Clinical and preclinical evaluation of recombinant PEG-IL-2 in human.

Menzel T, Schomburg A, Körfer A, Hadam M, Meffert M, Dallmann I, Casper S, Kirchner H, Poliwoda H, Atzpodien J. Menzel T, et al. Among authors: poliwoda h. Cancer Biother. 1993 Fall;8(3):199-212. doi: 10.1089/cbr.1993.8.199. Cancer Biother. 1993. PMID: 7804360 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters